OSA's Digital Library

Optics Express

Optics Express

  • Editor: Michael Duncan
  • Vol. 12, Iss. 19 — Sep. 20, 2004
  • pp: 4496–4510

Noninvasive, optical detection of diabetes: model studies with porcine skin

E.L. Hull, M.N. Ediger, A.H.T. Unione, E.K. Deemer, M.L. Stroman, and J.W Baynes  »View Author Affiliations


Optics Express, Vol. 12, Issue 19, pp. 4496-4510 (2004)
http://dx.doi.org/10.1364/OPEX.12.004496


View Full Text Article

Enhanced HTML    Acrobat PDF (432 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

An in vitro study was performed to evaluate noninvasive spectroscopic measurement of advanced glycation endproducts (AGEs) in skin collagen. A porcine dermis preparation was incubated in solutions simulating normal and hyperglycemic conditions. The AGEs kinetics of increase were determined by HPLC and GC/MS assays, and compared to near-infrared (NIR) and ultraviolet/visible fluorescence skin spectra. Multivariate analysis indicated that, although NIR did not discriminate between collagen samples exposed to different glucose concentrations, fluorescence changes were readily detected and correlated strongly with skin concentration of AGEs. These results suggest that measurement of skin AGEs by fluorescence spectroscopy may be useful for detection and diagnosis of type II diabetes.

© 2004 Optical Society of America

OCIS Codes
(170.1470) Medical optics and biotechnology : Blood or tissue constituent monitoring
(170.1580) Medical optics and biotechnology : Chemometrics
(170.6510) Medical optics and biotechnology : Spectroscopy, tissue diagnostics

ToC Category:
Research Papers

History
Original Manuscript: August 10, 2004
Revised Manuscript: September 9, 2004
Published: September 20, 2004

Citation
E. Hull, M. Ediger, A. Unione, E. Deemer, M. Stroman, and J. Baynes, "Noninvasive, optical detection of diabetes: model studies with porcine skin," Opt. Express 12, 4496-4510 (2004)
http://www.opticsinfobase.org/oe/abstract.cfm?URI=oe-12-19-4496


Sort:  Journal  |  Reset  

References

  1. S. Wild, G. Roglic, R. Sicree, A. Green, H. King, �??Global burden of diabetes mellitus in the year 2000,�?? in Global Burden of Disease 2000 (World Health Organization, Geneva, 2003).
  2. P. Hogan, T. Dall, P. Nikolov, American Diabetes Association, �??Economic Costs of Diabetes in the U.S. in 2002,�?? Diabetes Care 26, 917-932 (2003). [CrossRef] [PubMed]
  3. National diabetes fact sheet: general information and national estimates on diabetes in the United States 2000,�?? (Centers for Disease Control and Prevention, U.S. Department of Health and Human Services Atlanta, GA 2002).
  4. M.I. Harris, K.M. Flegal, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, R.R. Little, H.M. Wiedmeyer and D.D. Byrd-Holt, �??Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults, The Third National Health and Nutrition Examination Survey, 1988-1994,�?? Diabetes Care 21, 518-24 (1998). [CrossRef] [PubMed]
  5. The Diabetes Control and Complications Trial Research Group, �??The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,�?? N. Eng. J. Med. 329, 977-986 (1993).
  6. UK Prospective Diabetes Study (UKPDS) Group, �??Intensive blood-glucose control with sulphonylurias or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),�?? Lancet 352, 837-853 (1998). [PubMed]
  7. M.I. Harris and R.C. Eastman, �??Early detection of undiagnosed diabetes mellitus: a US perspective,�?? Diabetes Metab. Res. Rev. 16, 230-236 (2001). [CrossRef]
  8. S.M. Manley, L.C. Meyer, H.A.W. Neil, I.S. Ross, R.C. Turner and R.R. Holman, �??UKPDS 6 Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biologic risk factors,�?? Diabetes Research 13, 1-11 (1990)
  9. M.I. Harris, R. Klein, T.A. Welborn, and M.W. Knuiman, �??Onset of NIDDM Occurs at least 4-7 yr before clinical diagnosis,�?? Diabetes Care 15, 814-819 (1992). [CrossRef]
  10. American Diabetes Association Position Statement, �??Screening for Type 2 Diabetes,�?? Diabetes Care 26, S21-S24 (2003).
  11. Diabetes Detection Initiative, US Department of Health and Human Services,<a href="http://www.ndep.nih.gov/ddi/"> http://www.ndep.nih.gov/ddi/</a>
  12. M.M. Engelgau, K.M.V. Narayan, and W.H. Herman, �??Screening for Type 2 diabetes,�?? Diabetes Care 23, 1563-1580 (2000). [CrossRef] [PubMed]
  13. The Third National Health and Nutrition Examination Survey (NHANES III, 1988-94), National Center for Health Statistics, Centers for Disease Control and Prevention (1996), <a href="http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm">http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm</a>
  14. J.M. Mooy, P.A. Grootenhuis, H. de Vries, P.J. Kostense, C. Popp-Snijders, L.M. Bouter, R.J. Heine, �??Intraindividual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study,�?? Diabetologia 39, 298-305 (1996). [CrossRef] [PubMed]
  15. N. Verzijl, J. DeGroot, S.R. Thorpe, R.A. Bank, J.N. Shaw, T.J. Lyons, J.W.J. Bijlsam, F.P.J.G. Lafeber, J.W. Baynes, and J.M. TeKoppele, �??Effect of collagen turnover on the accumulation of advanced glycation end products,�?? J. Biol. Chem. 275, 39027-39031 (2000). [CrossRef] [PubMed]
  16. D.G. Dyer, J.A. Dunn, S.R. Thorpe, K.E. Bailie, T.J. Lyons, D.R. McCance, and J.W. Baynes, �??Accumulation of Maillard reaction products in skin collagen in diabetes and aging,�?? J. Clin. Invest. 91, 2463-2469 (1993). [CrossRef] [PubMed]
  17. R. McCance, D.G. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, J.W. Baynes, and T.J.Lyons, �??Maillard reaction products and theor relation to complications in insulin-dependent diabetes mellitus,�?? J. Clin. Invest. 91, 2470-2478 (1993). [CrossRef] [PubMed]
  18. B. Buckingham and K.M. Reiser, �??Relationship between the Content of Lysyl Oxidase-dependent Crosslinks in Skin Collagen, Nonenzymatic Glycosylation, and Long-Term Complications in type 1 Diabetes Mellitus,�?? J. Clin. Invest. 86, 1046-1054 (1990). [CrossRef] [PubMed]
  19. V.M. Monnier, O. Bautista, D. Kenny, D.R. Sell, J. Fogarty, W. Daahms, P.A. Cleary, J. Lachin, S. Genuth, and the DCCT Skin Collagen Ancillary Study Group, �??Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes,�?? Diabetes 48, 870-880 (1999). [CrossRef] [PubMed]
  20. P. Geladi, J. Nyström, J.W. Eriksson, A. Nilsson, F. Lithner, and B. Lindholm-Sethson, �??A multivariate NIR study of skin alterations in diabetic patients as compared to control subjects,�?? J. Near Infrared Spectroscopy 8, 217-27 (2000). [CrossRef]
  21. J. Nystrom, B. Lindholm-Sethson, L. Stenberg, S. Ollmar, J.W. Eriksson, and P. Geladi, �??Combined nearinfrared spectroscopy and multifrequency bioimpedance investigation of skin alterations in diabetes patients based on multivariate analyses,�?? Med. Biol. Eng. Comput. 4, 9-324 (2003). [CrossRef]
  22. H.M. Heise, S. Haiber, D. Ihrig, M. Licht, M. Stücker and C. Moll, �??Non-Invasive Diabetes Screening By Near Infrared Spectroscopy,�?? poster presentation at the 3rd Annual Meeting of the Diabetes Technology Society, San Francisco, CA, November 6-8, 2003.
  23. P. Koefoed Theil, T. Hansen, M. Larsen, O. Pedersen, and H. Lund-Andersen, �??Lens autofluorescence is increased in newly diagnosed patients with NIDDM,�?? Diabetologia 39, 1524-1527 (1996). [CrossRef]
  24. T. Abiko, A. Abiko, S. Ishiko, M. Takeda, S. Horiuchi, and A. Yoshida A, �??Relationship between autofluorescence and advanced glycation end products in diabetic lenses,�?? Exp. Eye Res. 68, 361-366 (1999). [CrossRef] [PubMed]
  25. N. Yu, B.S. Krantz, J.A. Eppstein, K.D. Ignotz, M.A. Samuels, J.R. Long, and J. Price, �??Development of a noninvasive diabetes screening device using the ratio of fluorescence to Rayleigh scattered light,�?? J. Biomed. Optics. 1, 280-288 (1996). [CrossRef]
  26. C.M. Fleming, H.T. Davis, R. Ratner, C.D. Brown, M.N. Ediger, E.L. Hull, R. Udell, and J.D. Maynard, �??Use of Near-Infrared Spectroscopy to Detect Diabetes Based on Noninvasive Skin Measurements,�?? poster presentation at the 3rd Annual Meeting of the Diabetes Technology Society, San Francisco, CA, November 6-8, 2003.
  27. D.L. Price, P.M. Rhett, S.R. Thorpe, and J.W. Baynes, �??Chelating activity of Advanced Glycation Endproduct inhibitors,�?? J. Biol. Chem. 276, 48967-48972 (2001). [CrossRef] [PubMed]
  28. L. Brancaleon, G. Lin, and N. Kollias, �??The in vivo fluorescence of tryptophan moieties in human skin increases with UV exposure and is a marker for epidermal proliferation,�?? J. Invest. Dermatol. 113, 977-982 (1999). [CrossRef] [PubMed]
  29. R. Gilles, G. Zonios, R.R. Anderson, and N. Kollilas, �??Fluorescence excitation spectroscopy provides information about human skin in vivo,�?? J. Invest. Dermatol. 115, 704-707 (2000). [CrossRef]
  30. J. Wu, M.S. Feld, and R.P. Rava, �??Analytical model for extracting intrinsic fluorescence in turbid media,�?? Appl. Opt. 32, 3585-3595 (1993). [CrossRef] [PubMed]
  31. Q. Zhang, M.G. Müller, J. Wu, and M.S. Feld, �??Turbidity-free fluorescence spectroscopy of biological tissue,�?? Opt. Lett. 25: 1451-1453 (2000). [CrossRef]
  32. M.G. Muller, I. Georgakoudi, Q. Zhang, and M.S. Feld, �??Intrinsic fluorescence spectroscopy in turbid media: disentagling the effects of scattering and absorption,�?? Appl. Opt. 25, 4633-4646 (2001). [CrossRef]
  33. C.M. Gardner, S.L. Jacques, and A.J. Welch, �??Fluorescence spectroscopy of tissue: recovery of intrinsic fluorescence from measured fluorescence,�?? Appl. Opt. 35:1780-1792 (1996). [CrossRef] [PubMed]
  34. J.C. Finlay, D.L. Conover, E.L. Hull, and T.H. Foster, �??Prophyrin bleaching and PDT-induced spectral changes are irradiance-dependent in ALA-sensitized normal rat skin in vivo,�?? Photochem. Photobiol. 73, 54-63 (2001). [CrossRef] [PubMed]
  35. H. Martens and T. Naes, Multivariate Calibration, (John Wiley and Sons, Chichester, 1989).
  36. D.M. Haaland and E.V. Thomas, �??Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information,�?? Anal. Chem. 60, 1193-1202 (1988). [CrossRef]
  37. H. Akaike, �??Information theory and an extension of the maximum likelihood principle,�?? Proc 2nd Int�??l Symp Information Theory, 267-281, (1973).
  38. M.H. Dominiczak, J. Bell, N.H. Cox, D.C. McCruden, S.K. Jones, A.Y. Finlay, I.W. Percy-Robb, and B.M. Frier, �??Increased collagen-linked fluorescence in skin of young patients with type 1 diabetes mellitus,�?? Diabetes Care 13, 468-72 (1990). [CrossRef] [PubMed]
  39. W. Hanna, D. Friesen, C. Bombardier, D. Gladman, and A. Hanna, �??Pathologic features of diabetic thick skin,�?? J. Am. Acad. Dermatol. 16, 546-553 (1987). [CrossRef] [PubMed]
  40. B.A. Buckingham, J. Uitto, C. Sandborg, T. Keens, T. Roe, G. Costin, F. Kaufman, B. Bernstein, B Landing, and A. Castellano, �??Scleroderma-like changes in insulin-dependent diabetes mellitus: Clinical and biochemical studies,�?? Diabetes Care 7, 163-169 (1984). [CrossRef] [PubMed]
  41. K.E.Juhani Airaksinen, P.I. Salmela, M.K. Linnaluoto, M.J. Ikaheimo, K. Ahola, and L.J. Ryhanen, �??Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen,�?? Cardiovasc. Res. 27, 942-945 (1993). [CrossRef] [PubMed]
  42. R. Reihsner, M. Melling, W. Pfeiler, and E.J. Menzel, �??Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation,�?? Clin. Biomech. 15, 379-386 (2000). [CrossRef]
  43. S Yeh, O.S. Khalil, C.F. Hanna, and S. Kantor, �??Near-infrared thermo-optical response of the localized reflectance of intact diabetic and nondiabetic human skin,�?? J. Biomed. Optics 8, 534-544 (2003). [CrossRef]
  44. C. Huberty, Applied Discriminant Analysis, (J Wiley and Sons, NY, 1994).

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.


« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited